Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative (Q73495289)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

K A LaBresh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P Owen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C Alteri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Reilly

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P S Albright

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A R Hordes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P A Shaftel

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T E Noonan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C A Stoukides

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A F Kaul

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

23A-29A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Effect of fluvastatin on low-density lipoprotein peak particle diameter.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Performance assessment model for guideline-recommended pharmacotherapy in the secondary prevention of coronary artery disease and treatment of left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Physician noncompliance with the 1993 National Cholesterol Education Program (NCEP-ATPII) guidelines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Persistence of use of lipid-lowering medications: a cross-national study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

The National Cholesterol Education Program: progress and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Variations in cholesterol management practices of U.S. physicians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Primary care practice adherence to National Cholesterol Education Program guidelines for patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Lipid lowering in a multidisciplinary clinic compared with primary physician management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900935-2

10.1016/S0002-9149(99)00935-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10695704%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference